Search Results
You are looking at 1 - 1 of 1 items for
- Author: Y Shuba x
- Refine by access: All content x
Search for other papers by L Lemonnier in
Google Scholar
PubMed
Search for other papers by R Lazarenko in
Google Scholar
PubMed
Search for other papers by Y Shuba in
Google Scholar
PubMed
Search for other papers by S Thebault in
Google Scholar
PubMed
Search for other papers by M Roudbaraki in
Google Scholar
PubMed
Search for other papers by G Lepage in
Google Scholar
PubMed
Search for other papers by N Prevarskaya in
Google Scholar
PubMed
Search for other papers by R Skryma in
Google Scholar
PubMed
Neuroendocrine (NE) differentiation of prostate epithelial/basal cells is a hallmark of advanced, androgen-independent prostate cancer, for which there is no successful therapy. Here we report for the first time on alterations in regulatory volume decrease (RVD) and its key determinant, swelling-activated Cl− current (ICl,swell), associated with NE differentiation of androgen-dependent LNCaP prostate cancer epithelial cells. NE-differentiating regimens, namely, chronic cAMP elevation or androgen deprivation, resulted in generally augmented ICl,swell and enhanced RVD. This occurred as a result of both the increased endogenous expression of ClC-3, which is a volume-sensitive Cl− channel involved, as we show, in ICl,swell in LNCaP (lymph-node carcinoma of the prostate) cells and the weaker negative ICl,swell control from Ca2+entering via store-dependent pathways. The changes in the RVD of NE-differentiated cells generally mimicked those reported for Bcl-2-conferred apoptotic resistance. Our results suggest that strengthening the mechanism that helps to maintain volume constancy may contribute to better survival rates of apoptosis-resistant NE cells.
